Related Experiment Videos
The WHO Onchocerciasis Control Programme: retrospect and prospects
R Le Berre1, J F Walsh, B Philippon
1World Health Organization, Geneva, Switzerland.
Summary
The West African Onchocerciasis Control Programme (OCP) effectively controls river blindness using insecticide treatments against the Simulium fly. Despite challenges like fly migration and insecticide resistance, the OCP is achieving its goals.
Area of Science:
- Public Health
- Tropical Medicine
- Vector-Borne Disease Control
Background:
- Onchocerciasis, or river blindness, is a debilitating parasitic disease transmitted by the Simulium fly.
- The World Health Organization's Onchocerciasis Control Programme in West Africa (OCP) was established to combat this disease.
- Experience from anti-locust campaigns informed the strategic planning of the OCP.
Purpose of the Study:
- To review the history and genesis of the OCP.
- To highlight the challenges faced by the OCP, including vector migration and insecticide resistance.
- To describe the management strategies and research undertaken to overcome these challenges.
Main Methods:
- Insecticide treatments targeting the breeding sites of the Simulium damnosum species complex, the vectors of onchocerciasis.
- Monitoring and management of vector migrations to prevent reinfestation of controlled areas.
- Research into insecticide resistance and development of control strategies.
Main Results:
- The OCP has achieved significant success in controlling onchocerciasis transmission in West Africa.
- Despite challenges such as fly migration and insecticide resistance, the program is largely meeting its objectives.
- Ongoing vector control and supplementary chemotherapy are projected to continue until 2004.
Conclusions:
- The OCP demonstrates the feasibility of large-scale vector control programs for tropical diseases.
- Integrated strategies combining vector control and chemotherapy are crucial for sustained onchocerciasis elimination.
- Continued vigilance and adaptive management are necessary to address evolving challenges in disease control.